Marianxhela Dajko

Dr. Marianxhela Dajko

Azienda Ospedaliera San Camillo-Forlanini, Rome, Lazio, Italy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Preventive Medicine
Verified
Journal Article
Closed access
LSLeuconoe Grazia Sisti
Leuconoe Grazia Sisti
MDMarianxhela Dajko
Marianxhela Dajko
PCP. Campanella
P. Campanella
ESE. Shkurti
E. Shkurti
WRWalter Ricciardi
Walter Ricciardi
Chiara de WaureChiara de Waure
Chiara de Waure

11 January 2022 in Hernia
Verified
Journal Article
Closed access
PDF file
CSCesare Stabilini
Cesare Stabilini
MGM.A. Garcia-Urena
M.A. Garcia-Urena
FBFrederik Berrevoet
Frederik Berrevoet
DCDiego Cuccurullo
Diego Cuccurullo
SGS. Capoccia Giovannini
S. Capoccia Giovannini
MCM. López Cano
M. López Cano

13 November 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
MTMichele Tulli
Michele Tulli
MRMassimo Re
Massimo Re
SBStefano Bondi
Stefano Bondi
LFLuigi Ferrante
Luigi Ferrante
MDMarianxhela Dajko
Marianxhela Dajko
MBMario Bussi
Mario Bussi

20 May 2020 in European Journal of Public Health
Verified
Journal Article
Closed access
GCGiovanni Corrao
Giovanni Corrao
FRFederico Rea
Federico Rea
FCFlavia Carle
Flavia Carle
MMMirko Di Martino
Mirko Di Martino
RPRossana De Palma
Rossana De Palma
MCMatteo Corradin
Matteo Corradin
Background: Multimorbidity is a growing concern for healthcare systems, with many countries experiencing demographic transition to older population profiles. A simple multisource comorbidity score (MCS) has been recently developed and validated. A very large real-world investigation was conducted with the aim of measuring inequalities in the MCS distribution across Italy. Methods: Beneficiaries of the Italian National Health Service aged 50–85 years who in 2018 were resident in one of the 10 participant regions formed the study population (15.7 million of the 24.9 million overall resident in Italy). MCS was assigned to each beneficiary by categorizing the individual sum of the comorbid values (i.e. the weights corresponding to the comorbid conditions of which the individual suffered) into one of the six categories denoting a progressive worsening comorbidity status. MCS distributions in women and men across geographic partitions were compared. Results: Compared with beneficiaries from northern Italy, those from centre and south showed worse comorbidity profile for both women and men. MCS median age (i.e. the age above which half of the beneficiaries suffered at least one comorbidity) ranged from 60 (centre and south) to 68 years (north) in women and from 63 (centre and south) to 68 years (north) in men. The percentage of comorbid population was lower than 50% for northern population, whereas it was around 60% for central and southern ones. Conclusion: MCS allowed of capturing geographic variability of multimorbidity prevalence, thus showing up its value for addressing health policy in order to guide national health planning.

1 November 2021 in Digestive and Liver Disease
Verified
Journal Article
Closed access
Luca MieleLuca Miele
Luca Miele
Alessia PernaAlessia Perna
Alessia Perna
MDMarianxhela Dajko
Marianxhela Dajko
MZMaria A. Zocco
Maria A. Zocco
AMAntonio De Magistris
Antonio De Magistris
GSGabriella Silvestri
Gabriella Silvestri

1 January 2020
Verified
Journal Article
Closed access
AFA. M. R. Favuzzi
A. M. R. Favuzzi
AVA. Venuti
A. Venuti
Carmine BrunoCarmine Bruno
Carmine Bruno
MNM. A. Nicolazzi
M. A. Nicolazzi
MFM. Fuorlo
M. Fuorlo
Antonio ManciniAntonio Mancini
Antonio Mancini